Fulcrum Therapeutics (FULC) Return on Sales (2020 - 2025)
Fulcrum Therapeutics' (FULC) quarterly Return on Sales came in at 0.02% in Q2 2025, down 3.0% year-on-year from 0.02% in Q2 2024, and down 37.97% on a QoQ basis from 0.02% in Q4 2024.
Fulcrum Therapeutics (FULC) Return on Sales (2020 - 2025) Analysis & Trends
Fulcrum Therapeutics (FULC) has 6 years of Return on Sales data on file, last reported at 0.02% in Q2 2025.
- On a quarterly basis, Return on Sales fell 3.0% year-over-year to 0.02% in Q2 2025; TTM through Jun 2025 was 0.02%, a 1.0% decrease from a year earlier, with the FY2024 full-year figure at 0.01%, up 97.0% from the prior year.
- Return on Sales for Q2 2025 stood at 0.02%, down from 0.02% in the prior quarter.
- Over the last five years, Return on Sales for FULC reached as high as 0.01% in Q2 2024 and fell as low as 2.81% in Q4 2022.
- Historically, Return on Sales has averaged 0.42% across 5 years, with a median of 0.2% in 2021.
- Across the five-year window, Return on Sales slumped 271 bps in 2022 and surged 231 bps in 2023, its largest moves.
- Year by year, Return on Sales stood at 0.1% in 2021, then slumped by 2689 bps to 2.81% in 2022, then jumped by 82 bps to 0.49% in 2023, then jumped by 97 bps to 0.02% in 2024, then tumbled by 38 bps to 0.02% in 2025.
- Per Business Quant data, the three most recent Return on Sales figures were 0.02% in Q2 2025, 0.02% in Q4 2024, and 0.01% in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.00% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 0.00% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.00% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 0.00% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Fulcrum Therapeutics | 286.57 Mn | 286.57 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -0.02% |
| Dec 31, 2024 | -0.02% |
| Sep 30, 2024 | -0.01% |
| Jun 30, 2024 | 0.01% |
| Mar 31, 2024 | -0.71% |
| Dec 31, 2023 | -0.49% |
| Sep 30, 2023 | -0.53% |
| Jun 30, 2023 | -0.35% |
| Mar 31, 2023 | -1.03% |
| Dec 31, 2022 | -2.81% |
| Sep 30, 2022 | -0.23% |
| Jun 30, 2022 | -0.19% |
| Mar 31, 2022 | -0.36% |
| Dec 31, 2021 | -0.10% |
| Sep 30, 2021 | -0.20% |
| Jun 30, 2021 | -0.09% |
| Mar 31, 2021 | -0.05% |
| Dec 31, 2020 | -0.04% |
| Sep 30, 2020 | -0.21% |
| Jun 30, 2020 | -0.17% |